| Primary |
| Chylothorax |
10.5% |
| Acromegaly |
9.9% |
| Carcinoid Tumour |
8.2% |
| Carcinoid Syndrome |
7.6% |
| Pancreatitis |
7.0% |
| Acute Lymphocytic Leukaemia |
5.8% |
| Diarrhoea |
5.8% |
| Hepatorenal Syndrome |
5.3% |
| Hypoglycaemia |
5.3% |
| Erdheim-chester Disease |
4.7% |
| Neuroendocrine Tumour |
4.7% |
| Frequent Bowel Movements |
4.1% |
| Metastases To Liver |
3.5% |
| Hepatic Neoplasm Malignant |
2.9% |
| Hyperinsulinaemia |
2.9% |
| Insulinoma |
2.9% |
| Gastric Haemorrhage |
2.3% |
| Pituitary Tumour |
2.3% |
| Small Cell Carcinoma |
2.3% |
| Crohn's Disease |
1.8% |
|
| Vomiting |
12.5% |
| Medication Error |
9.1% |
| Death |
8.0% |
| Thrombocytopenia |
8.0% |
| Necrotising Colitis |
6.8% |
| Drug Ineffective |
5.7% |
| Pancreatitis Acute |
5.7% |
| Pyrexia |
4.5% |
| Bradycardia |
3.4% |
| Cardiac Arrest |
3.4% |
| Diarrhoea |
3.4% |
| Hypoglycaemia |
3.4% |
| Hypoglycaemic Seizure |
3.4% |
| Loss Of Consciousness |
3.4% |
| Neoplasm Malignant |
3.4% |
| Pituitary Tumour Removal |
3.4% |
| Swelling |
3.4% |
| Tachycardia |
3.4% |
| Weight Decreased |
3.4% |
| Cardio-respiratory Distress |
2.3% |
|
| Secondary |
| Neuroendocrine Carcinoma |
14.7% |
| Carcinoid Syndrome |
13.6% |
| Drug Use For Unknown Indication |
11.5% |
| Premedication |
5.7% |
| Anaesthesia |
5.4% |
| Carcinoid Tumour |
5.4% |
| Chylothorax |
3.9% |
| Hypertension |
3.9% |
| Hypoglycaemia |
3.9% |
| Product Used For Unknown Indication |
3.9% |
| Somnolence |
3.6% |
| Acromegaly |
3.2% |
| Hepatorenal Syndrome |
3.2% |
| Pituitary Tumour Benign |
3.2% |
| Nausea |
2.9% |
| Small Cell Carcinoma |
2.9% |
| Erdheim-chester Disease |
2.5% |
| Acute Lymphocytic Leukaemia |
2.2% |
| Anaemia |
2.2% |
| Diarrhoea |
2.2% |
|
| Posture Abnormal |
18.6% |
| Diarrhoea |
9.3% |
| Hypokalaemia |
8.1% |
| Vision Blurred |
5.8% |
| Death |
4.7% |
| Necrotising Colitis |
4.7% |
| Small Intestinal Obstruction |
4.7% |
| Vomiting |
4.7% |
| Drug Interaction |
3.5% |
| Hypoglycaemia |
3.5% |
| Hypoglycaemic Seizure |
3.5% |
| Normal Newborn |
3.5% |
| Occult Blood Positive |
3.5% |
| Thrombocytopenia |
3.5% |
| Urinary Incontinence |
3.5% |
| Vasculitis |
3.5% |
| Visual Field Defect |
3.5% |
| Weight Decreased |
3.5% |
| Abdominal Distension |
2.3% |
| Aortic Injury |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.4% |
| Drug Use For Unknown Indication |
14.3% |
| Diarrhoea |
5.5% |
| Prophylaxis |
4.9% |
| Nausea |
4.7% |
| Hypertension |
4.2% |
| Graft Versus Host Disease |
4.1% |
| Prophylaxis Of Nausea And Vomiting |
3.1% |
| Pain |
2.9% |
| Antifungal Prophylaxis |
2.6% |
| Neoplasm |
2.6% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Multiple Myeloma |
2.4% |
| Depression |
2.1% |
| Infection Prophylaxis |
2.1% |
| Bone Marrow Conditioning Regimen |
2.0% |
| Carcinoid Tumour |
2.0% |
| Acute Myeloid Leukaemia |
2.0% |
| Acute Lymphocytic Leukaemia |
1.9% |
| Prophylaxis Against Graft Versus Host Disease |
1.9% |
|
| Vomiting |
18.2% |
| Weight Decreased |
13.2% |
| Portal Vein Thrombosis |
6.9% |
| Respiratory Failure |
6.9% |
| Enterocolitis |
5.0% |
| Rhabdomyolysis |
4.4% |
| White Blood Cell Count Decreased |
4.4% |
| Ileus |
3.8% |
| Multi-organ Failure |
3.8% |
| Serotonin Syndrome |
3.8% |
| Death |
3.1% |
| Renal Failure |
3.1% |
| Renal Failure Acute |
3.1% |
| Somnolence |
3.1% |
| Tachycardia |
3.1% |
| Thrombocytopenia |
3.1% |
| Tremor |
3.1% |
| Cardiac Arrest |
2.5% |
| Hyperbilirubinaemia |
2.5% |
| Injection Site Mass |
2.5% |
|
| Interacting |
| Gastric Haemorrhage |
46.7% |
| Pruritus |
23.3% |
| Constipation |
20.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
6.7% |
| Pancreatic Fistula |
3.3% |
|
| Drug Interaction |
42.9% |
| Respiratory Distress |
28.6% |
| Therapeutic Procedure |
28.6% |
|
